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Cardiac experimental electrophysiology is in need of a well-deﬁned Minimum Information Standard for
recording, annotating, and reporting experimental data. As a step towards establishing this, we present
a draft standard, called Minimum Information about a Cardiac Electrophysiology Experiment (MICEE).
The ultimate goal is to develop a useful tool for cardiac electrophysiologists which facilitates and
improves dissemination of the minimum information necessary for reproduction of cardiac electro-
physiology research, allowing for easier comparison and utilisation of ﬁndings by others. It is hoped that
this will enhance the integration of individual results into experimental, computational, and conceptual
models. In its present form, this draft is intended for assessment and development by the research
community. We invite the reader to join this effort, and, if deemed productive, implement the Minimum
Information about a Cardiac Electrophysiology Experiment standard in their own work.
 2011 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Here, we present a draft Minimum Information Standard for
recording, annotating, and reporting experimental cardiac elec-
trophysiology data, which we are calling Minimum Information
about a Cardiac Electrophysiology Experiment (MICEE). The
concept is that for relevant studies, this information will be made
available in an online repository and referenced in related publi-
cations. Our hope is that this reporting standard will develop into
a tool used by the experimental cardiac electrophysiology
community to facilitate and improve recording and dissemination
of the minimum information necessary for reproduction of cardiac
electrophysiology experimental research, via contextualisation to
allow for easier comparison and usage of ﬁndings by others, and to
enhance the integration of results into other experimental,
computational, and conceptual models.
Throughout the scientiﬁc community, there is growing recog-
nition that open-access data-sharing promotes research trans-
parency, assessment and validation of experimental data, and
design of new experiments, furthering discovery from past work
and the development of broader computational and/or conceptual
models that are based ﬁrmly on experimental insight (Smith and
Noble, 2008). This is reﬂected by the current requirements of
some funding agencies and journals for data sharing, as well as the
concerted efforts of various institutions in its promotion and
implementation (Cragin et al., 2010; Nelson, 2009). While there are
examples of very useful data sharing resources, such as the data-
base of Genotypes and Phenotypes (dbGAP; http://www.ncbi.nlm.
nih.gov/gap/) for storing genome-wide association study data, or
the Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/
geo/) for mRNA data, many real and perceived barriers need to be
overcome before such resources can achieve their full potential.
These include reluctance to contribute data that has taken years to
collect, concerns about data misuse and/or misattribution, worries
about intellectual property rights associated with data, and the
additional time, effort, and resources required to make data and
their contextualisation via meta-data accessible by others (Craginet al., 2010; Nelson, 2009). An additional fundamental problem is
a lack of clear and useful reporting standards and associated
infrastructure. Minimum Information Standards and reporting
guidelines are now recognized as an important step towards
establishing effective data use and re-use, thus optimising data
utilisation and enabling experimental reproducibility e something
that is already an explicit requirement for the scientiﬁc research
and communication process.
Any useful set of reporting standards is necessarily discipline-
speciﬁc, describing what raw- and meta-data should be made
available, and how this should be formatted for general use, so that
necessary and sufﬁcient information is provided to allow repro-
duction of experimental interventions and study procedures. While
this is critical for well-informed evaluation of results and conclu-
sions, the associated overhead should remain minimal, to
encourage compliance (Taylor et al., 2007). The identiﬁcation of
a minimally necessary and sufﬁcient set of parameters is a difﬁcult
task, confounded by the overwhelming diversity of scientiﬁc
practises and information in any given ﬁeld.
In recent years, there has been a growing interest in identifying
formalised reporting requirements for experimental and compu-
tational research. Current efforts are being brought together under
the Minimum Information about a Biomedical or Biological Inves-
tigation (MIBBI) umbrella (http://www.mibbi.org/), aimed at
uniting the various communities developingMinimum Information
Standards for the description of data sets and the workﬂows by
which theywere generated (Kettner et al., 2010; Taylor et al., 2008).
Currently, however, no set of reporting standards exist for cardiac
electrophysiology experimentation, contributing to a lack of
consistency in the information reported upon publication. This has
resulted from neither negligence nor ill intent. Constraints on time
and resources, as well as output-speciﬁc content and formatting
demands, make the task of reporting in a standardised fashion
appear burdensome and (possibly) not worth the extra effort. One
might regard it as ironic, that the current mode may in fact be
a larger drain on time and resources for the community overall,
than the alternative. To reproduce experiments from published
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without in-depth knowledge of all materials, procedures, and
interventions (which will be rare in ﬁelds with a low proportion of
‘routine’ research activities). This situation has beenmadeworse by
the progressive reduction in space allocated to the description of
methods in many journals (in some cases this has been partly
remedied by online supplemental information, although stand-
ardisation of such sections might still aid experimental reproduc-
ibility). Lack of reporting standards also makes it particularly
difﬁcult to enable data utilisation across ﬁelds, such as by compu-
tational modellers who may be less familiar with determinants of
experimental studies that are ‘at the fringes’ of experimental design
(while pH or ambient temperature may be obvious parameters to
watch out for, osmotic pressure of solutions or the supplier of
a transgenic strain may feature less prominently on the list of
possible confounding aspects). Furthermore, ‘negative’ results, i.e.,
the ﬁnding that a particular intervention does not give rise to
a hypothesised response, are published far too rarely (even though
the only thing ‘negative’ about these data are that they do not reach
the public domain), such that positive results, even when scarce,
may dominate perception. This results in an abundance of inad-
vertently repeated experiments and a profound publication bias
that hampers scientiﬁc understanding (Schooler, 2011), although
there are current efforts to correct this (such as with the Journal of
Negative Results in Biomedicine; http://www.jnrbm.com/).
Thus, standardised reporting guidelines may help to ensure
availability of the information needed to reproduce a study, or to
not attempt it, avoiding wasted time and resources, which
increases overall productivity. Additionally, increased emphasis on
the integration of insight from different levels of structural
complexity (Kohl et al., 2010), and a renewed focus on the trans-
lation of information learnt through basic science to the clinic,
requires more stringent control and documentation of experi-
mental conditions and protocols (especially important in the post-
genomic era, with the increasingly common use of small animal
models to mimic human conditions and to explore treatment
possibilities). Careful consideration should be paid to what are
seemingly inevitable experimental restrictions, such as caused by
sub-optimal experimental design, systematic experimental error,
and parameter variations outside the control of the experimen-
talist. This will also beneﬁt efforts to conduct quantitative analysis
and computational modelling, by facilitating inclusion of important
parameters that potentially inﬂuence results, such as factors
accounting for subject speciﬁc differences (e.g., age and sex). While
one cannot predict all of the information that might be necessary
for post hoc computational and/or conceptual ‘modelling’ e espe-
cially with the rapid evolution of this ﬁeld e having reported what
is currently understood to constitute the most important factors
contributing to an experimental outcome will be of signiﬁcant
utility for the identiﬁcation and validation of novel hypotheses
(Greenstein and Winslow, 2011; Rudy, 2000).
2. Proposed draft of a minimum information standard for
cardiac electrophysiology experimentation
The goal of this paper is to present a draft of a Minimum
Information Standard for cardiac electrophysiology experimenta-
tion. This has been modelled after the Minimum Information about
a Neuroscience Investigation (MINI; http://www.carmen.org.uk/
standards) standard (Gibson et al., 2009), but tailored for the
speciﬁc needs of cardiac electrophysiology. It contains a draft of
what is believed to be an explicit minimum set of information that
is necessary for reproduction of experimental cardiac electro-
physiology research and its integration into other experimental or
computational models, while hopefully remaining general enoughto cover a majority of cases in the ﬁeld. A signiﬁcant proportion of
this information would normally already appear in the Methods
sections of publications. Nonetheless, it has been included here, as
having all information in one place will improve efﬁciency of
access. The MICEE standard has been organised into the following
ﬁve sections, which are believed to encapsulate the most important
aspects of the majority of cardiac electrophysiology experiments:
1. Material
2. Environment
3. Protocols
4. Recordings
5. Analysis
Below we describe the rationale for these sections, and the
general information essential to each of them, in order to clarify the
content of the proposed draft reporting standard, and to aid
broader discussion and further development of the proposal. The
complete MICEE standard can be found in Appendix A. The
described reporting standard is ‘a draft sequence’, and very much
open to further development in the light of community needs and
preferences.We do not speciﬁcally discuss each individual element,
but hope that all elements follow from the principles discussed
above. Finally, to illustrate the utility of the MICEE standard, an
example (using a study recently published by some of the authors
(Iribe et al., 2009)) is provided in Appendix B (as an online
supplement), which highlights the need for information not con-
tained in ‘the usual’ Methods section.
1. Material: This section gives details of the subject(s) under
investigation. Depending on the nature of the study, the type(s)may
be human, whole animal, isolated heart, isolated or engineered
tissue, isolated, cultured, or stem cells, or cell fragments (e.g.,
membrane patches), and subheadings are provided for each. Each of
these subheadings has its own speciﬁc characteristics, relating to
features that are increasingly recognized as important to cardiac
electrophysiology (e.g., sex, developmental stage, genetic variation,
disease background, and husbandry, including diet, environmental
enrichment, and light cycle). Additionally, it includes information
about sample preparation and maintenance, focusing on aspects
such asmethod of animal dispatch, anatomical origin of the sample,
isolation procedure, cell selection process, and growth, culture, and
differentiating conditions. This information is essential to the
outcome of cardiac electrophysiology studies, as it is arguably one of
the most important acute determinants of the quality, viability, and
reproducibility of experimental model systems.
2. Environment: Information contained in this section, relating
to environmental conditions in which an experiment is conducted,
is also vital to the interpretation and comparison of cardiac elec-
trophysiology results, but is often not well-controlled or monitored
(e.g., ‘room temperature’), with speciﬁc details underreported in
publications (and perhaps increasingly so, which would be
aworrying trend). Included factors range from sample temperature
(e.g., temperature at the site of experimentation, not in a ﬂuid
reservoir for example) and solution characteristics, to ﬂow rates,
bath volume, and details about the presence of chemicals, dyes,
gases, or drugs. This not only makes information available for later
study veriﬁcation, but also highlights the importance of a range of
parameters for experimental control, potentially encouraging
closer monitoring of relevant conditions, where possible.
3. Protocols: This heading provides a description of the exper-
imental protocols of a study. Including detailed descriptions of
experimental procedures is becoming progressively more impor-
tant, as an increasing number of journals are either reducing the
space provided for publishing this information (often due to
economical and citation-impact related pressures), or relegating it
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other sections, requiring a sufﬁciently detailed account of proce-
dures and interventions, as cardiac electrophysiology draws on an
extremely wide array of experimental techniques and model
systems, often with laboratories following their own individually-
tailored protocols. Also, this is the area where scientiﬁc origi-
nality is, perhaps, the most important driver of progress. As such,
the prescription of a ﬁrm reporting standard for information of this
type is neither possible nor desirable.
4. Recordings: This section addresses the speciﬁcs of equipment
and software used to record and pre-process signals in an experi-
ment, including relevant parameters of operation. The importance
of this information may not be as self-evident as other aspects
described above, which may result in severe under-reporting in
publications. This includes features such as detailed description of
timing control, data sampling rates, ﬁltering and smoothing, bit
depth, gain, and dynamic range, all of which can greatly affect the
nature and information content of data. For example, with patch-
clamp recordings, technical aspects are essential for appropriate
application of the technique and errors in factors such as series
resistance and voltage-clamp control can lead to errors in the basic
properties of currents, resulting in misinterpretation of results and
misleading conclusions.
5. Analysis: This part of the reporting standard provides infor-
mation on the software and methods used in data processing to
extract information, including details of post hoc ﬁltering, normal-
isation, interpolation, inclusion and exclusion criteria, n number(s),
and statisticalmethods. Its importance is fairly clear, as outcomes can
be signiﬁcantly alteredbydatamanipulation, but still, detail provided
in publications tends to be insufﬁcient for adequate reproduction. An
additional feature of this section is the inclusion of example(s) of raw
and processed data (from the same recording), which will allow
others to assess whether they are able to replicate described
approaches (and which is also often omitted from publications).
3. Implementing and developing the MICEE standard
It is important to repeat that this reporting standard is meant, in
its present form, as a place to start. The set of minimum information
must develop from experience and input from the greater commu-
nity, which may include both growth and reduction of currently
envisaged categories and parameters. The hope is that, with time,
adherence to minimum reporting standards will become second
nature, as is the current expectation that the composition of solutions
and their pH formpartof anymethods section in thisﬁeld. Thiswould
help to address some of the challenges associated with data sharing,
experimental reproducibility, model interrelation, and correlation of
experimental and computational studies in cardiac electrophysiology
research. The concept is also that the MICEE repository, discussed
below, will allow for dissemination of so-called ‘negative’ ﬁndings,
that often remain unpublished. This may avoid repetition of experi-
ments and improve scientiﬁc understanding, and when pertinent,
can be cited in future publications.
Progress could be facilitated by a research program to catalogue
past work (similar to what has been done for a single recent study
in Appendix B). Such shared access to ‘retrospective’ communica-
tions has been developed, with signiﬁcant success, for computa-
tional cardiac electrophysiology modelling, which is beneﬁting
from the increasing use of a standardised format for communica-
tion and modelling (Nickerson and Buist, 2009), called Cell Markup
Language (CellML) (Cuellar et al., 2003). The CellML model repos-
itory now contains over 250 cardiac electrophysiology cell models
(see http://models.cellml.org/electrophysiology/), curated and
tested to different levels, making models and associated meta-data
(like original publications) easily accessible.Once the reporting standard begins to converge, it will be
important to incorporate it into the MIBBI framework (see http://
www.mibbi.org/index.php/Projects/MICEE) and to work with
other communities to explore standardized nomenclatures and
combined workﬂow elements, to avoid double work and incom-
patibility of outputs. For instance, the Virtual Physiological Human
(VPH) (Fenner et al., 2008; Hunter et al., 2010; Hunter and
Viceconti, 2009; Kohl and Noble, 2009) and Physiome
(Bassingthwaighte et al., 2009; Bassingthwaighte, 1997; Hunter
et al., 2002; Smith et al., 2009) projects are promoting the devel-
opment of model and data encoding standards for the computa-
tional modelling community, along with their associated minimum
information requirements. Efforts are also underway to establish
uniform data standards for clinical cardiovascular electrophysi-
ology studies and procedures, to serve as a basis for research and
practice databases (Buxton et al., 2006; Weintraub et al., 2011). It
will be essential to promote compatibility with these activities,
especially for use of experimental data in computational model
building and validation. Additionally, it could prove helpful if the
formal reporting standard e once endorsed more broadly by the
community e would be adopted by one or more professional
societies. Equally crucial will be the question whether leading
journals in the ﬁeld may be convinced to identify ‘MICEE-
compatible data reporting’ as a desirable approach.
Most importantly, beyond the desire to increase awareness of
the need for Minimum Information Standards in cardiac electro-
physiology experimentation, we intend to initiate action. Thus, the
authors of this communication are making a commitment to
adhere to the proposed reporting standard for a twelve-month
period, starting at the beginning of 2012, by recording the then
identiﬁed MICEE information for all of their relevant studies. Upon
study completion, this information will be made available in
a repository maintained by the Johns Hopkins University Cardio-
Vascular Research Grid (accessible at http://www.micee.org/).
When relevant, MICEE entries will link-out to the digital object
identiﬁers (DOI) of publications, and be referenced in the related
papers with a citable identiﬁcation. This test of utility will help in
assessing and shaping the MICEE approach, and we invite others in
the community to join us in this effort. We also request feedback on
how the reporting standard might be improved, which will be
possible via a public notice board on the MICEE.org website, to
facilitate community discussion. Finally, once the standard begins
to gain broader acceptance by cardiac electrophysiologists, an
oversight committee will be established to manage the process of
standard reﬁnement and future extensions of MICEE.
4. Present difﬁculties and challenges ahead
Even amongst those who believe Minimum Information Stan-
dards are necessary and important, a common argument against
their development is that “it is a nearly impossible task”. Other
valid criticisms include the concern that their implementation is
associated with too much work, or e conversely e that they do not
go far enough. However, if one regards the status quo as not ideal, it
is hard to argue that useful progress can not be made. It is obvious
that emergence of a complete consensus by a research community
on any reporting standard is highly unlikely. This applies to the
proposed MICEE standard, and it includes the authors of this paper.
There is, however, agreement amongst the authors that there is
a need to agree on, and deﬁne (standardise) the minimum infor-
mation needs for cardiac electrophysiology experimentation. We
realise that a complete description of any experiment is
unachievable, but believe that the proposed standard encompasses
key features necessary for the effective use of information by other
researchers. Besides, ‘exact’ repetition of an experiment with
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improbable (and not usually warranted or desired). Proper docu-
mentation of the factors that may be most important to experi-
mental outcomes, however, is an attainable and relevant goal.
It is clear that convergence to an agreement on a ‘ﬁnal’ MICEE
standardwill need time, but once a standard has been accepted, the
question remains as to the best ways of encouraging ‘compliance’.
As with most change, a combination of ‘stick and carrot’ tends to be
most productive. Wielding the stick, one could imagine an
approachwhere thosewho have the authority demand compliance.
Examples would include funding agencies (which can make it
a condition of support), scientiﬁc societies (which can establish it as
a precedent), and journals (which can make it part of publication
policies, or simply formalise their methods sections and online
supplements to provide information congruent to the proposed
standard). By and large, it seems that scientists generally do not
respond well to (new) dogmas and demands, as even widely
accepted (and exceedingly valuable) precedents, for instance the
système international d’unités (SI), have had (and still have) a hard
time to penetrate certain traditional barriers. Ultimately, the key
question is: “what is in it for me?”. If and when a new tool (e.g.,
a reporting standard) proves to be productive and has clear value,
for example saving time, effort, and resources, it turns itself into the
‘carrot’. A useful example of this is the now widely-accepted
standardisation approach in the Systems Biology ﬁeld, the
Systems Biology Markup Language (SBML) (Hucka et al., 2003).
The trick, then, will be to develop MICEE to a level where it
becomes a tool of utility. Therefore, the MICEE standard is a form of
self-regulation, shaped by the greater community, such that the ﬁnal
product will be formed by end-users, with the aim of making it
a useful time savingmeasure, rather than a hindrance. In this context,
it may be constructive to consider MICEE standards early in the
research process, as collection of data at the time of study execution
will facilitate its later dissemination. Thus, the goal is for MICEE to
also be useful in creating ‘internal’ collections, for tracking data and
meta-data associated with experimental protocols and recordings,
for generating publications and academic theses and reports (e.g.,
PhD dissertations), for sharing among colleagues and collaborators,
and for laboratory training purposes. For this, a scientist controlled
embargo system may be important (Cragin et al., 2010), and
emulating the functionality of existing ‘staging repository’ tools, such
as the Data Staging Repository (DataStar; http://datastar.mannlib.
cornell.edu/), may be a constructive approach.
Attitudes towards reporting standards and their implementation
are changing inmanyother areas of bioscience research, spearheaded
by an active and organised minimum information community: the
MIBBI portal currently lists 32 Minimum Information Standards (see
http://www.mibbi.org/index.php/MIBBI_portal). Common to those
reporting standards that have been successful is the availability of
technical support, in the form of software for formatting experi-
mental data and recording associated meta-data and repositories for
deposition, storage, and retrieval of this information, including soft-
ware and user-interfaces for efﬁcient database searches and data
exportation (with links to publications and cross-links to other
experiments and sources of information). In general, there are three
necessary elements for reporting standard utilisation: (i) deﬁnition of
the Minimum Information Standard, (ii) a syntax for expression of
data, and (iii) a meta-data standard for semantics (via ontologies to
ensure the use of accepted terminology). Our aim, at this point, is to
propose and develop (i). In the near future, this will need to be fol-
lowed by (ii) and (iii), to ensure efﬁcient automated search processes.
For this, an XML-based standard for time varying data may be useful,
such as is being developed through the BioSignal Markup Language
(BioSignalML) (Brooks, 2009). Ultimately, further development will
require a commitment from national, regional, and/or privatefunding agencies, and while resources are always in short supply,
cost-beneﬁt considerations suggest that this would be in the best
interest of all involved.
As always, it is helpful to try to learn from the experience of
previous minimum information efforts. The pioneering, and
maybe most successful, example of a reporting standard was
published 10 years ago, the Minimum Information About
a Microarray Experiment (MIAME) standard (Brazma et al., 2001).
The assertion at the time was that, to make data usable for anal-
ysis, everything relevant had to be recorded systematically
(Brazma, 2009). Perhaps most important to its success was the fact
that a majority of scientiﬁc journals made submission of MIAME-
compliant data to public repositories mandatory. Also essential
was its intuitive interface, where users could place queries to
search databases. The relevant databases (for instance dbGAP),
curate, analyse, and transform microarray data, making it widely
accessible. However, even with the general adoption of MIAME
principles, it can be difﬁcult to obtain desired microarray data
(Ioannidis et al., 2009), which has been attributed mainly to the
fact that the initial lack of standard computer-readable formats for
representing information has limited its utility (Brazma, 2009).
This has been improved by speciﬁcation of formats by the Func-
tional Genomics Data (FGED) Society (http://www.mged.org/,
which was founded in 1999 as the Microarray Gene Expression
Data (MGED) Society). Another lesson has been that it is important
to allow ‘inheritance’ of database information, and to ease linking
with previously published resources (e.g., via PubMed). Protocol
description should be facilitated, wherever possible, by use of
standard templates, or reuse of existing protocols (with optional
modiﬁcations). However, care must be taken not to lose infor-
mation regarding the rationale behind a researcher’s experi-
mental choices, such as study design, conditions, and protocols, as
this is critically important for understanding. Such meta-data may
not come across in checklists and tables, but rather only through
original narrative, so appropriate use of freeform text ﬁelds is
essential, especially for protocol description. Furthermore, it is
conceivable that codiﬁcation of reporting might promote adoption
of preset patterns that could impact imagination and creativity.
So, a workable compromise must be sought, as loosely prescribed
sections may encourage substitution of jargon, abbreviation,
shorthand, and ambiguously terse description in place of a full
explanation. Related to this is the worry that, as a secondary
source implemented in an online database, MICEE data will be
subject to errors, omissions, and misrepresentations that would
not occur with peer-reviewed publication. Peer-reviewed publi-
cations are not free of inaccuracies themselves, of course, and the
only truly reliable source is the ‘original’ e the investigator who
performed the studies. Discrepancies between peer-review and
MICEE reporting would be minimised by explicitly linking to
published papers and database sets. Curation of the MICEE data-
base will remain a critical issue (experience with other reposito-
ries, for instance the CellMLmodel repository, has shown that only
veriﬁed entries tend to be reliable sources), especially for studies
without an associated publication, and a mechanism for report
checking will need to be developed. These are all areas where it
will be useful to adopt technologies already under development or
in use by the MIBBI community.
5. Conclusion
The time is ripe for open-access sharing of published data in the
cardiac electrophysiology community. The ﬁeld would beneﬁt from
Minimum Information Standards and reporting guidelines.
Successful efforts in other research areas have hinged on general
acceptance of, and compliance to, such reporting standards. Cardiac
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deﬁned Minimum Information Standard, and as a step towards
establishing this, we propose Minimum Information about
a Cardiac Electrophysiology Experiment (MICEE; see the draft
presented in Appendix A, for consideration and development by
the greater community). A considered user interface is hoped to
make compliance as pain-free as possible, and we hope that with
time this approach will manifest itself as an improvement over
current practice. As an initial test of its utility, during 2012, the
authors of this communication will adhere to the then identiﬁed
standard, and we invite the reader to join this effort, by evaluating
and implementing the Minimum Information about a Cardiac
Electrophysiology Experiment standard.
Editors’ note
Please see also related communications in this issue by Cooper
et al. (2011) and Winslow and Greenstein (2011).
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Appendix A
Proposed Minimum Information Standard: Minimum Informa-
tion about a Cardiac Electrophysiology Experiment (MICEE)
1. Material
1.1 Type (Human/Whole Animal/Isolated Heart/Isolated Tissue/
Isolated Cells/Cell Fragments/Engineered Tissue/Cultured
Cells/Stem Cells)
1.2 Ethical approval
1.3 Human
1.3.1 Gender
1.3.2 Age/developmental stage/body mass index
1.3.3 Clinical information/disease background (health status/
known pathology/drug treatment/etc.)
1.3.4 Genetic variation
1.3.5 Familial history/pedigree
1.3.6 Point within circadian cycle/point within hormonal cycle
1.3.7 Conscious, sedated, or anesthetised (agent(s)/supplier(s)/
etc.)/open or closed chest/acute or chronic intervention
1.4 Whole Animal/Isolated Heart/Isolated Tissue/Isolated Cells/
Cell Fragments
1.4.1 Gender
1.4.2 Age/developmental stage/weight
1.4.3 Genus/species/strain
1.4.4 Supplier
1.4.5 Genetic variation (type/means)
1.4.6 Disease model/state (type/means/assessment)
1.4.7 Husbandry (diet/housing type/environmental enrich-
ment/dayenight cycle/etc.)
1.4.8 Point within circadian cycle/point within hormonal
cycle
1.4.9 Conscious, sedated, or anesthetised (agent(s)/supplier(s)/
etc.)/open or closed chest/acute or chronic intervention
1.4.10 Method of animal dispatch
1.4.11 Anatomical origin of sample
1.4.12 Isolation procedure1.4.13 Time and method to ﬁnal preparation (temperature/
solution/electrical/mechanical stimulation/mode of
storage/etc.)
1.4.14 Isolated heart mode of operation (working or Lan-
gendorff/constant pressure or constant ﬂow/balloon/
etc.)
1.4.15 Cell selection process/single cell conﬁrmation/morpho-
logical status before and during recordings
1.5 Engineered Tissue
1.5.1 Cellular and acellular composition
1.5.2 Growth conditions (time/temperature/medium/
substrate/structure/bioreactor/supplements/electrical
and/or mechanical stimulation/mode of storage/etc.)
1.6 Cultured Cells
1.6.1 Cell line
1.6.2 Source/anatomical origin of sample
1.6.3 Passage (number/conditions/density/etc.)
1.6.4 Culture conditions (time/temperature/medium/gas/
substrate/structure/supplements/electrical and/or
mechanical stimulation/mode of storage/etc.)
1.6.5 Cell selection process/single cell conﬁrmation/morp-
hological status before and during recordings
1.7 Stem Cells
1.7.1 Source/anatomical origin of sample
1.7.2 Passage (number/conditions/density/etc.)
1.7.3 Culture/differentiating conditions (time/temperature/
medium/gas substrate/structure/supplements/electrical
and/or mechanical stimulation/mode of storage/etc.)
1.7.4 Cell selection process/single cell conﬁrmation/morp-
hological status before and during recordings
2. Environment
2.1 Sample temperature
2.2 Gas partial pressures
2.3 Solution (composition/buffer/pH/osmolarity/etc.)
2.4 Flow rates
2.5 Bath volume
2.6 Chemicals, dyes, and/or drugs (concentration(s)/supplier(s)/
solvent(s)/etc.)
3. Protocols
3.1 Study design (randomisation/blinding/subject and/or prepa-
ration inclusion and/or exclusion criteria/number of subjects
and/or preparations/number of rejected subjects and/or
preparations/number of subject and/or preparation replace-
ments/etc.)
3.2 Sufﬁcientlydetailed accountof procedures and interventions
for offsite reproduction of study by providing time resolved
protocols (indication of intervention and recording timings/
recordings of baseline, intervention, and washout/etc.)
4. Recordings
4.1 Time window of recording
4.2 Spatial location of recording
4.3 Electrical Recordings
4.3.1 Equipment (electrodes/pre-ampliﬁers/ampliﬁers/
recorders/etc.)
4.3.2 A/D conversion (sampling rate/channels/bit depth/gain/
dynamic range/etc.)
4.4 Optical Measurements
4.4.1 Equipment (optical mapping system/microscope/light
sources/ﬁlters/lenses/lens numerical aperture/detector
speciﬁcations/etc.)
4.4.2 Settings (pinhole/gain/offset/spatial and temporal
sampling/scan modes/etc.)
4.5 Other Recordings
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etc.)
4.5.2 A/D conversion (sampling rate/channels/bit depth/
gain/dynamic range/etc.)
4.6 Timing control (for multiple recording systems/stimulation/
recording/imaging etc.)
4.7 Hardware based data processing (ﬁltering/smoothing/binning/
etc.)
4.8 Software environment (operating system/acquisition program
version and supplier/etc.)
5. Analysis
5.1 Software environment (operating system/program version
and supplier/etc.)
5.2 n number(s) (number of preparations and observations/
number of preparations and observations per subject/etc.)
5.3 Observations inclusion and exclusion criteria/number of
rejected observations
5.4 Signal-to-noise (method of calculation/etc.)
5.5 Software based data processing (ﬁltering/smoothing/
binning/averaging/background signal removal/normal-
isation/interpolation/extrapolation/deconvolution/etc.)
5.6 Calculated parameters (QT-interval/QRS duration/endocar-
dial activation/conduction velocity/action potential dura-
tion to speciﬁed level of repolarisation/peak current/etc.)
5.7 Sufﬁciently detailed description of statistical methods for
offsite reproduction
5.8 Example(s) of raw and processed data (from the same
recording)Appendix B. Supplementary information
Supplementarymaterial associatedwith this paper can be found
in the online version at doi:10.1016/j.pbiomolbio.2011.07.001.
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